Knowledge Mobilization Activities to Support Decision-Making by Youth, Parents and Adults: Study Protocol

NCT05358990 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 997

Last updated 2022-12-14

No results posted yet for this study

Summary

Coronavirus Disease (COVID-19) recommendations are usually developed for healthcare professionals (for example Doctors, health organizations, etc.). It is important to make sure that these recommendations can be used and understood by everyone. This study aims to make COVID-19 recommendations more accessible and understandable for parents and caregivers, adults, and youth.

Conditions

Interventions

OTHER

Plain Language Recommendation (PLR)

New easy to read COVID-19 recommendations available on the COVID19 Living Map of Recommendations and Gateway to Contextualization (RecMap).

OTHER

Standard Language Version (SLV)

Original recommendation as initially published by the guideline organization.

Sponsors & Collaborators

  • Western University

    collaborator OTHER
  • The Hospital for Sick Children

    collaborator OTHER
  • University of Alberta

    collaborator OTHER
  • McMaster University

    lead OTHER

Principal Investigators

  • Holger J Schunemann, MD, PHD · McMaster University

  • Kevin Pottie · Western University

  • Martin Offringa · The Hospital for Sick Children Research Institute

  • Nancy Butcher · The Hospital for Sick Children Research Institute

  • Lisa Hartling · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-25
Primary Completion
2022-10-25
Completion
2022-10-25

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05358990 on ClinicalTrials.gov